LFCR Lifecore Biomedical, Inc.
Healthcare$4.93-1.00%OpenMarket Cap: $184.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
8.89
P/S
1.37
EV/EBITDA
115.24
DCF Value
$-10.16
FCF Yield
5.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
31.2%
Operating Margin
-0.1%
Net Margin
-25.2%
ROE
-146.7%
ROA
-15.1%
ROIC
-0.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $23.2M | 19.2% | $-4.7M | $-15.0M | $— | — |
| Q2 null | $44.4M | 35.8% | $2.3M | $-8.0M | $— | — |
| Q1 null | $31.1M | 25.0% | $-3.1M | $-10.0M | $— | — |
| Q4 null | $36.4M | 38.4% | $5.3M | $-1.1M | $— | — |
| FY null | $128.9M | 31.3% | $-17.2M | $-38.7M | $— | — |
| Q3 null | $35.2M | 28.0% | $-9.0M | $-14.8M | $— | — |
| Q2 null | $32.6M | 34.0% | $-2.0M | $-6.6M | $— | — |
| Q1 null | $24.7M | 21.8% | $-11.6M | $-16.2M | $— | — |
| Q4 null | $37.9M | 45.6% | $2.1M | $-7.1M | $— | — |
| FY null | $128.3M | 32.6% | $-8.8M | $12.0M | $— | — |
| Q3 null | $35.7M | 33.3% | $-895.0K | $15.6M | $— | — |
| Q2 2024 | $30.1M | 33.0% | $-1.5M | $14.2M | $0.39 | — |